Endothelial targeting of antioxidants
Endothelial targeting of antioxidants
批准号:
9261598
负责人:
Vladimir R Muzykantov
金额:
$32.2万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-15 至 2020-03-31
关键词:
AcuteAcute Lung InjuryAddressAdverse effectsAffinityAnimal ModelAnimalsAntibodiesAntioxidantsBindingBinding SitesBloodBlood VesselsCardiovascular systemClathrinClinicalCritical CareDangerousnessDataDecision MakingDiseaseDrug usageElementsEndosomesEndothelial CellsEndotheliumEnzymesEpitopesFormulationGoalsGrantHumanHuman PathologyHydrogen PeroxideInflammationInflammatoryInjuryIschemiaLeadLigand BindingLigandsLightLungLung TransplantationMediator of activation proteinMedicalMethodsModalityModelingMolecularMorbidity - disease rateNeurologicOxidative StressPathologicPathway interactionsPatientsPharmaceutical PreparationsPharmacotherapyPilot ProjectsPre-Clinical ModelProblem SolvingPulmonary InflammationReactive Oxygen SpeciesReagentSafetySepsisSignal TransductionSiteSourceSpecificityStrokeSuperoxidesTNF geneTestingTherapeuticTherapeutic InterventionTimeTissuesTranslationsVascular EndotheliumVesicleWorkantioxidant enzymeantioxidant therapybasecytokinedesigneffective therapyexperienceintercellular cell adhesion moleculemortalitymouse modelprotective effectprototypepublic health relevancereceptorresponserisk benefit ratiosuccesstargeted treatmentvascular inflammation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Vascular oxidative stress and inflammation are intertwined mutually propagating mechanisms of tissue injury in many human maladies including cardiovascular, neurological and pulmonary acute dangerous critical care conditions. Much evidence implicate reactive oxygen species produced by endothelial cells in these conditions in response to cytokines and other pathological agents. Antioxidants have no natural affinity to endothelium and do not quench ROS in endothelial intracellular compartments. We achieve this goal by immunotargeting antioxidants such as antioxidant enzymes (SOD and catalase) into specific sub-types of endothelial endosomes. Results of our previous and pilot studies show that this approach affords remarkable protection in animal models of acute pulmonary inflammation. Further, new findings of collaborative dual targeting open avenues for concomitant delivery of synergizing SOD and catalase. In this project that capitalizes on the wealth of our experience in targeted antioxidants and on unique collaborative opportunities offered by PENN Lung Transplant Center, we will make the decisive steps towards translation of our approach to medical practice via pursuing the following Specific Aims. In Aim 1 we will maximize precision and effect of targeted antioxidants by addressing them to caveolar vs clathrin endosomes. In Aim 2 we will address the mechanism and utility of dual collaborative targeting of SOD and catalase. In Aim 3 we will appraise protective and adverse effects of lead formulations in animals, devise translational targeted antioxidants based on clinically acceptable elements and test their targeting antioxidants in human lungs. All components of the study including unique reagents, models and methods are in place in our collaborative team. Implementation of this project will shed light on poorly understood aspects of mechanisms of vascular oxidative stress and inflammation and provide new specific and potent treatment for human pathologies involving these conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BC-mediated delivery of thromboprophylaxis
-
批准号:10277205
-
项目类别:
-
资助金额:$66.0万
-
财政年份:2021
-
负责人:Vladimir R Muzykantov
-
依托单位:
Dual drug delivery to lung/blood interface in respiratory infections.
-
批准号:10179690
-
项目类别:
-
资助金额:$74.23万
-
财政年份:2021
-
负责人:Vladimir R Muzykantov
-
依托单位:
BC-mediated delivery of thromboprophylaxis
-
批准号:10475755
-
项目类别:
-
资助金额:$66.66万
-
财政年份:2021
-
负责人:Vladimir R Muzykantov
-
依托单位:
Dual drug delivery to lung/blood interface in respiratory infections.
-
批准号:10614476
-
项目类别:
-
资助金额:$72.11万
-
财政年份:2021
-
负责人:Vladimir R Muzykantov
-
依托单位:
Dual drug delivery to lung/blood interface in respiratory infections.
-
批准号:10393610
-
项目类别:
-
资助金额:$72.69万
-
财政年份:2021
-
负责人:Vladimir R Muzykantov
-
依托单位:
BC-mediated delivery of thromboprophylaxis
-
批准号:10652489
-
项目类别:
-
资助金额:$66.66万
-
财政年份:2021
-
负责人:Vladimir R Muzykantov
-
依托单位:
Vascular Targeting of Nanocarriers for RNA
-
批准号:10343691
-
项目类别:
-
资助金额:$80.18万
-
财政年份:2021
-
负责人:Vladimir R Muzykantov
-
依托单位:
Vascular Targeting of Nanocarriers for RNA
-
批准号:10093767
-
项目类别:
-
资助金额:$72.62万
-
财政年份:2021
-
负责人:Vladimir R Muzykantov
-
依托单位:
Vascular Targeting of Nanocarriers for RNA
-
批准号:10560629
-
项目类别:
-
资助金额:$79.28万
-
财政年份:2021
-
负责人:Vladimir R Muzykantov
-
依托单位:
Vascular delivery of nanocarriers by erythrocyres
-
批准号:9922385
-
项目类别:
-
资助金额:$70.55万
-
财政年份:2018
-
负责人:Vladimir R Muzykantov
-
依托单位:
Vascular delivery of nanocarriers by erythrocyres
-
批准号:10153877
-
项目类别:
-
资助金额:$70.22万
-
财政年份:2018
-
负责人:Vladimir R Muzykantov
-
依托单位:
Targeted nanomedicine for ALI and I/R
-
批准号:8961511
-
项目类别:
-
资助金额:$56.94万
-
财政年份:2015
-
负责人:Vladimir R Muzykantov
-
依托单位:
Targeted nanomedicine for ALI and I/R
-
批准号:9097813
-
项目类别:
-
资助金额:$56.94万
-
财政年份:2015
-
负责人:Vladimir R Muzykantov
-
依托单位:
Targeting novel biotherapeutics to endothelium
-
批准号:9096887
-
项目类别:
-
资助金额:$54.96万
-
财政年份:2015
-
负责人:Vladimir R Muzykantov
-
依托单位:
Targeted nanomedicine for ALI and I/R
-
批准号:9231481
-
项目类别:
-
资助金额:$56.94万
-
财政年份:2015
-
负责人:Vladimir R Muzykantov
-
依托单位:
Drug delivery by carrier erythrocytes
-
批准号:9204426
-
项目类别:
-
资助金额:$63.6万
-
财政年份:2014
-
负责人:Vladimir R Muzykantov
-
依托单位:
Drug delivery by carrier erythrocytes
-
批准号:8998056
-
项目类别:
-
资助金额:$65.75万
-
财政年份:2014
-
负责人:Vladimir R Muzykantov
-
依托单位:
Drug delivery by carrier erythrocytes
-
批准号:8918194
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:Vladimir R Muzykantov
-
依托单位:
Drug delivery by carrier erythrocytes
-
批准号:8787490
-
项目类别:
-
资助金额:$64.76万
-
财政年份:2014
-
负责人:Vladimir R Muzykantov
-
依托单位:
2012 Drug Carriers in Medicine and Biology Gordon Research Conference
-
批准号:8396077
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2012
-
负责人:Vladimir R Muzykantov
-
依托单位:
海外基金